Last €34.44 EUR
Change Today +0.69 / 2.03%
Volume 0.0
As of 2:08 AM 08/21/14 All times are local (Market data is delayed by at least 15 minutes).

abaxis inc (AXS) Snapshot

Open
€34.43
Previous Close
€33.75
Day High
€34.44
Day Low
€34.43
52 Week High
07/30/14 - €35.34
52 Week Low
10/24/13 - €23.07
Market Cap
775.6M
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
22.5M
EX-Date
08/29/14
P/E TM
--
Dividend
€0.40
Dividend Yield
0.21%
Current Stock Chart for ABAXIS INC (AXS)

abaxis inc (AXS) Related Businessweek News

No Related Businessweek News Found

abaxis inc (AXS) Details

Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care settings to provide blood constituent measurements for clinicians worldwide. It operates in two segments, Medical Market and Veterinary Market. The company offers Piccolo Xpress chemistry analyzers with blood constituent measurements for use in human patient care; and Piccolo profiles that are single-use medical reagents. It also provides VetScan VS2, a chemistry, electrolyte, immunoassay, and blood gas analyzer delivering results from a sample of whole blood, serum, or plasma; VetScan HM5; and VetScan HM2, VetScan HMII, and VetScan HMT hematology instruments, as well as reagent kits for veterinary applications. In addition, the company offers VetScan VSpro that assists the diagnosis and evaluation of suspected bleeding disorders, toxicity/poisoning, disseminated intravascular coagulation evaluation, hepatic disease, monitoring therapy, and disease progression states; VetScan VSpro coagulation test to evaluate prothrombin and the activated partial thromboplastin times; VetScan VSpro fibrinogen test for in-vitro determination of fibrinogen levels in equine platelet poor plasma from a citrated stabilized whole blood sample; and i-STAT that delivers blood gas, electrolyte, chemistry, and hematology results. Further, it provides VetScan Canine Heartworm rapid test to detect dirofilaria immitis in canine whole blood, serum, or plasma; VetScan Canine Lyme rapid test to detect Borrelia burgdorferi in canine whole blood, serum, or plasma; Vetscan Canine Parvovirus rapid test to detect canine parvovirus antigen in feces; and VetScan Giardia rapid test to detect Giardia cyst antigens in canine feces, as well as veterinary reference laboratory diagnostic and consulting services. Abaxis, Inc. sells its products through direct sales force and independent distributors. The company was founded in 1989 and is headquartered in Union City, California.

Founded in 1989

abaxis inc (AXS) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $478.1K
Co-Founder, Vice President of Government Affa...
Total Annual Compensation: $258.5K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $258.5K
Chief Operations Officer
Total Annual Compensation: $258.5K
Chief Technology Officer
Total Annual Compensation: $258.5K
Compensation as of Fiscal Year 2014.

abaxis inc (AXS) Key Developments

Abaxis, Inc. Declares Quarterly Cash Dividend, Payable on September 17, 2014

Abaxis, Inc. announced that its Board of Directors declared a quarterly dividend of $0.10 per common share to be paid on September 17, 2014, to all shareholders of record as of the close of business on September 3, 2014.

Abaxis, Inc. Reports Un-Audited Consolidated Earnings Results for the First Quarter Ended June 30, 2014

Abaxis, Inc. reported un-audited consolidated earnings results for the first quarter ended June 30, 2014. For the quarter, the company reported revenues of $47.5 million, as compared with revenues of $43.2 million for the comparable period last year, an increase of 10%. The company reported income from operations of $7.4 million or $0.33 per diluted share compared to $4.6 million or $0.21 per diluted share, income before income tax provision of $7.5 million compared to $5.0 million and net income of $4.7 million or $0.21 per diluted share compared to $3.2 million or $0.14 per diluted share for the last year.

Abaxis Mulls Acquisitions

Abaxis, Inc. (NasdaqGS:ABAX) is seeking acquisitions. Clint Severson, Chairman, President and Chief Executive Officer of Abaxis said, "We're always looking at opportunities to acquire new things. And there are we're probably looking at two or three opportunities at any one given time. And so that's how we use our cash."

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AXS:GR €34.44 EUR +0.69

AXS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AXS.
View Industry Companies
 

Industry Analysis

AXS

Industry Average

Valuation AXS Industry Range
No financial data is available for AXS.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABAXIS INC, please visit www.abaxis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.